The formulation reduced the side effects associated with the non-specific distribution of 131I. In addition, immobilized 131I-PD-L1 can enhance immunogenic cell death and stimulate the maturation of multiple immune cells that induce a systemic anti-tumor immune response [169]. This evidence concerns the gene CD274 and neoplasm.